Sang Kweon Jeon

Title: Sang Kweon Jeon: Inventor of a Stable Crystalline Drug Form

Introduction

Sang Kweon Jeon is an inventor based in Seoul, South Korea. His work includes a patent concerning a crystalline form of a pharmaceutical compound. Jeon is associated with Mitoimmune Therapeutics Inc. and has 1 patent listed in the information provided.

Latest Patents

Jeon’s patent, “Crystalline Forms of 5-[(1,1-Dioxido-4-Thiomorpholinyl)Methyl]-2-Phenyl-N-(Tetrahydro-2H-Pyran-4-yl)-1H-Indol-7-Amine,” describes Crystalline Form A of the compound.

The patent states that this form has physical and chemical advantages over amorphous and other crystalline forms. It is described as resistant to denaturation during prolonged exposure to harsh conditions, with low water sorption and stability during pressure application or pulverization. These properties may support formulation and extended storage.

Career Highlights

A key highlight of Jeon’s listed patent work is its focus on the stability and practical handling of a pharmaceutical compound in crystalline form. The invention addresses properties relevant to formulation, processing, and storage.

Collaborations

Jeon is associated with Mitoimmune Therapeutics Inc. The provided information also names Soon Ha Kim and Hye Kyung Chang as coworkers, though it does not specify their roles in the patent or their particular contributions.

Conclusion

Sang Kweon Jeon’s listed invention focuses on a stable crystalline form designed to offer advantages in pharmaceutical formulation and long-term storage.